{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:08:13Z","timestamp":1790140093721,"version":"4.0.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T00:00:00Z","timestamp":1494288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1038\/mp.2017.102","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T09:08:29Z","timestamp":1494320909000},"page":"1745-1755","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Genetic and pharmacological antagonism of NK1 receptor prevents opiate abuse potential"],"prefix":"10.1038","volume":"23","author":[{"given":"A J","family":"Sandweiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M I","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Moutal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Davidson-Knapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A K","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V J","family":"Hruby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T M","family":"Largent-Milnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T W","family":"Vanderah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,9]]},"reference":[{"key":"136_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1056\/NEJMra1604339","volume":"375","author":"MA Schuckit","year":"2016","unstructured":"Schuckit MA. Treatment of opioid-use disorders. N Engl J Med 2016; 375: 357\u2013368.","journal-title":"N Engl J Med"},{"key":"136_CR2","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain\u2014United States. JAMA 2016; 315: 1624\u20131645.","journal-title":"JAMA"},{"key":"136_CR3","first-page":"93","volume":"6","author":"AJ Sandweiss","year":"2015","unstructured":"Sandweiss AJ, Vanderah TW. The pharmacology of neurokinin receptors in addiction: prospects for therapy. Subst Abuse Rehabil 2015; 6: 93\u2013102.","journal-title":"Subst Abuse Rehabil"},{"key":"136_CR4","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/j.1476-5381.2010.00824.x","volume":"161","author":"TM Largent-Milnes","year":"2010","unstructured":"Largent-Milnes TM, Yamamoto T, Nair P, Moulton JW, Hruby VJ, Lai J et al. Spinal or systemic TY005, a peptidic opioid agonist\/neurokinin 1 antagonist, attenuates pain with reduced tolerance. Br J Pharmacol 2010; 161: 986\u20131001.","journal-title":"Br J Pharmacol"},{"key":"136_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S0163-1047(85)91538-9","volume":"43","author":"U Staubli","year":"1985","unstructured":"Staubli U, Huston JP. Central action of substance P: possible role in reward. Behav Neural Biol 1985; 43: 100\u2013108.","journal-title":"Behav Neural Biol"},{"key":"136_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/286155a0","volume":"286","author":"TL Yaksh","year":"1980","unstructured":"Yaksh TL, Jessell TM, Gamse R, Mudge AW, Leeman SE. Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo. Nature 1980; 286: 155\u2013157.","journal-title":"Nature"},{"key":"136_CR7","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1523\/JNEUROSCI.12-02-00483.1992","volume":"12","author":"SW Johnson","year":"1992","unstructured":"Johnson SW, North RA. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 1992; 12: 483\u2013488.","journal-title":"J Neurosci"},{"key":"136_CR8","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1523\/JNEUROSCI.09-01-00258.1989","volume":"9","author":"PW Mantyh","year":"1989","unstructured":"Mantyh PW, Gates T, Mantyh CR, Maggio JE. Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues. J Neurosci 1989; 9: 258\u2013279.","journal-title":"J Neurosci"},{"key":"136_CR9","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1111\/j.1460-9568.2006.04792.x","volume":"23","author":"TM Korotkova","year":"2006","unstructured":"Korotkova TM, Brown RE, Sergeeva OA, Ponomarenko AA, Haas HL. Effects of arousal- and feeding-related neuropeptides on dopaminergic and GABAergic neurons in the ventral tegmental area of the rat. Eur J Neurosci 2006; 23: 2677\u20132685.","journal-title":"Eur J Neurosci"},{"key":"136_CR10","unstructured":"Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Elsevier Academic Press, 2005."},{"key":"136_CR11","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.2647","volume":"31","author":"PD Hsu","year":"2013","unstructured":"Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 2013; 31: 827\u2013832.","journal-title":"Nat Biotechnol"},{"key":"136_CR12","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/978-1-60761-753-2_15","volume":"649","author":"DY Guschin","year":"2010","unstructured":"Guschin DY, Waite AJ, Katibah GE, Miller JC, Holmes MC, Rebar EJ. A rapid and general assay for monitoring endogenous gene modification. Methods Mol Biol 2010; 649: 247\u2013256.","journal-title":"Methods Mol Biol"},{"key":"136_CR13","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc 2013; 8: 2281\u20132308.","journal-title":"Nat Protoc"},{"key":"136_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1124\/jpet.113.205245","volume":"347","author":"TM Largent-Milnes","year":"2013","unstructured":"Largent-Milnes TM, Brookshire SW, Skinner DP Jr, Hanlon KE, Giuvelis D, Tamamoto T et al. Building a better analgesic: multifunctional compounds that address injury-induced pathology to enhance analgesic efficacy while eliminating unwanted side effects. J Pharmacol Exp Ther 2013; 347: 7\u201319.","journal-title":"J Pharmacol Exp Ther"},{"key":"136_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","volume":"67","author":"JL Hylden","year":"1980","unstructured":"Hylden JL, Wilcox GL. Intrathecal morphine in mice: a new technique. Eur J Pharmacol 1980; 67: 313\u2013316.","journal-title":"Eur J Pharmacol"},{"key":"136_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","volume":"32","author":"K Hargreaves","year":"1988","unstructured":"Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988; 32: 77\u201388.","journal-title":"Pain"},{"key":"136_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0196-9781(82)90141-3","volume":"3","author":"VS Seybold","year":"1982","unstructured":"Seybold VS, Hylden JL, Wilcox GL. Intrathecal substance P and somatostatin in rats: behaviors indicative of sensation. Peptides 1982; 3: 49\u201354.","journal-title":"Peptides"},{"key":"136_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1124\/jpet.113.205245","volume":"347","author":"TM Largent-Milnes","year":"2013","unstructured":"Largent-Milnes TM, Brookshire SW, Skinner DP Jr, Hanlon KE, Giuvelis D, Yamamoto T et al. A novel efficacious antinociceptive opioid without dependence, reward, or emetic properties in animals. J Pharmacol Exp Ther 2013; 347: 7\u201319.","journal-title":"J Pharmacol Exp Ther"},{"key":"136_CR19","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/0031-9384(76)90029-9","volume":"17","author":"TL Yaksh","year":"1976","unstructured":"Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976; 17: 1031\u20131036.","journal-title":"Physiol Behav"},{"key":"136_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0304-3959(92)90041-9","volume":"50","author":"SH Kim","year":"1992","unstructured":"Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992; 50: 355\u2013363.","journal-title":"Pain"},{"key":"136_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejphar.2008.01.011","volume":"583","author":"TW Vanderah","year":"2008","unstructured":"Vanderah TW, Largent-Milnes T, Lai J, Porreca F, Houghten RA, Menzaghi F et al. Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors. Eur J Pharmacol 2008; 583: 62\u201372.","journal-title":"Eur J Pharmacol"},{"key":"136_CR22","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1523\/JNEUROSCI.4054-04.2005","volume":"25","author":"YY Xie","year":"2005","unstructured":"Xie YY, Herman DS, Stiller CO, Gardell LR, Ossipov MH, Lai J et al. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance. J Neurosci 2005; 25: 409\u2013416.","journal-title":"J Neurosci"},{"key":"136_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.pain.2011.09.021","volume":"153","author":"TM Marshall","year":"2012","unstructured":"Marshall TM, Herman DS, Largent-Milnes TM, Badghisi H, Zuber K, Holt SC et al. Activation of descending pain-facilitatory pathways from the rostral ventromedial medulla by cholecystokinin elicits release of prostaglandin-E2 in the spinal cord. Pain 2012; 153: 86\u201394.","journal-title":"Pain"},{"key":"136_CR24","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/j.1460-9568.2010.07134.x","volume":"31","author":"A Rocha","year":"2010","unstructured":"Rocha A, Kalivas PW. Role of the prefrontal cortex and nucleus accumbens in reinstating methamphetamine seeking. Eur J Neurosci 2010; 31: 903\u2013909.","journal-title":"Eur J Neurosci"},{"key":"136_CR25","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1021\/jm101023r","volume":"54","author":"T Yamamoto","year":"2011","unstructured":"Yamamoto T, Nair P, Largent-Milnes TM, Jacobsen NE, Davis P, Ma SW et al. Discovery of a potent and efficacious peptide derivative for delta\/mu opioid agonist\/neurokinin 1 antagonist activity with a 2',6'-dimethyl-L-tyrosine: in vitro in vivo, and NMR-based structural studies. J Med Chem 2011; 54: 2029\u20132038.","journal-title":"J Med Chem"},{"key":"136_CR26","doi-asserted-by":"crossref","first-page":"ES9","DOI":"10.36076\/ppj.2012\/15\/ES9","volume":"15","author":"L Manchikanti","year":"2012","unstructured":"Manchikanti L, Helm S, Fellows B, Janata JW, Pampati V, Grider JS et al. Opioid epidemic in the United States. Pain Physician 2012; 15: ES9\u201338.","journal-title":"Pain Physician"},{"key":"136_CR27","unstructured":"American Society of Addiction Medicine. Opioid Addiction Facts & Figures. Chevy Chase, MD: American Society of Addiction Medicine 2016. Available at: http:\/\/www.asam.org\/docs\/default-source\/advocacy\/opioid-addiction-disease-facts-figures.pdf ."},{"key":"136_CR28","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/acem.12323","volume":"21","author":"J Perrone","year":"2014","unstructured":"Perrone J, Mycyk MB. A challenging crossroad for emergency medicine: the epidemics of pain and pain medication deaths. Acad Emerg Med 2014; 21: 334\u2013336.","journal-title":"Acad Emerg Med"},{"key":"136_CR29","doi-asserted-by":"publisher","first-page":"e42365","DOI":"10.1371\/journal.pone.0042365","volume":"7","author":"EB Margolis","year":"2012","unstructured":"Margolis EB, Toy B, Himmels P, Morales M, Fields HL. Identification of rat ventral tegmental area GABAergic neurons. PLoS ONE 2012; 7: e42365.","journal-title":"PLoS ONE"},{"key":"136_CR30","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1113\/jphysiol.2006.117069","volume":"577","author":"EB Margolis","year":"2006","unstructured":"Margolis EB, Lock H, Hjelmstad GO, Fields HL. The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons? J Physiol 2006; 577: 907\u2013924.","journal-title":"J Physiol"},{"key":"136_CR31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1460-9568.2006.05263.x","volume":"25","author":"T Yamaguchi","year":"2007","unstructured":"Yamaguchi T, Sheen W, Morales M. Glutamatergic neurons are present in the rat ventral tegmental area. Eur J Neurosci 2007; 25: 106\u2013118.","journal-title":"Eur J Neurosci"},{"key":"136_CR32","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.neuroscience.2008.01.046","volume":"152","author":"RG Nair-Roberts","year":"2008","unstructured":"Nair-Roberts RG, Chatelain-Badie SD, Benson E, White-Cooper H, Bolam JP, Ungless MA. Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat. Neuroscience 2008; 152: 1024\u20131031.","journal-title":"Neuroscience"},{"issue":"(21)","key":"136_CR33","doi-asserted-by":"publisher","first-page":"7811","DOI":"10.1523\/JNEUROSCI.1504-11.2011","volume":"31","author":"Y Xia","year":"2011","unstructured":"Xia Y, Driscoll JR, Wilbrecht L, Margolis EB, Fields HL, Hjelmstad GO. Nucleus accumbens medium spiny neurons target non-dopaminergic neurons in the ventral tegmental area. J Neurosci 2011; 31(21): 7811\u20137816.","journal-title":"J Neurosci"},{"key":"136_CR34","doi-asserted-by":"publisher","first-page":"14707","DOI":"10.1523\/JNEUROSCI.2144-14.2014","volume":"34","author":"EB Margolis","year":"2014","unstructured":"Margolis EB, Hjelmstad GO, Fujita W, Fields HL. Direct bidirectional mu-opioid control of midbrain dopamine neurons. J Neurosci 2014; 34: 14707\u201314716.","journal-title":"J Neurosci"},{"key":"136_CR35","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neuroscience.2014.05.032","volume":"282C","author":"M Morales","year":"2014","unstructured":"Morales M, Root DH. Glutamate neurons within the midbrain dopamine regions. Neuroscience 2014; 282C: 60\u201368.","journal-title":"Neuroscience"},{"key":"136_CR36","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/309795a0","volume":"309","author":"PW Mantyh","year":"1984","unstructured":"Mantyh PW, Pinnock RD, Downes CP, Goedert M, Hunt SP. Correlation between inositol phospholipid hydrolysis and substance P receptors in rat CNS. Nature 1984; 309: 795\u2013797.","journal-title":"Nature"},{"key":"136_CR37","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.1073\/pnas.85.20.7820","volume":"85","author":"S De Biasi","year":"1988","unstructured":"De Biasi S, Rustioni A. Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of spinal cord. PNAS 1988; 85: 7820\u20137824.","journal-title":"PNAS"},{"key":"136_CR38","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1152\/jn.00450.2006","volume":"97","author":"D Budai","year":"2007","unstructured":"Budai D, Khasabov SG, Mantyh PW, Simone DA. NK-1 receptors modulate the excitability of ON cells in the rostral ventromedial medulla. J Neurophysiol 2007; 97: 1388\u20131395.","journal-title":"J Neurophysiol"},{"key":"136_CR39","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0304-3940(00)01406-3","volume":"291","author":"Q Zhou","year":"2000","unstructured":"Zhou Q, Le Greves P, Ragnar F, Nyberg F. Intracerebroventricular injection of the N-terminal substance P fragment SP(1-7) regulates the expression of the N-methyl-D-aspartate receptor NR1, NR2A and NR2B subunit mRNAs in the rat brain. Neurosci Lett 2000; 291: 109\u2013112.","journal-title":"Neurosci Lett"},{"key":"136_CR40","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.neubiorev.2009.02.005","volume":"33","author":"Y Guo","year":"2009","unstructured":"Guo Y, Wang HL, Xiang XH, Zhao Y. The role of glutamate and its receptors in mesocorticolimbic dopaminergic regions in opioid addiction. Neurosci Biobehav Rev 2009; 33: 864\u2013873.","journal-title":"Neurosci Biobehav Rev"},{"key":"136_CR41","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nature07579","volume":"457","author":"B Lu","year":"2009","unstructured":"Lu B, Su Y, Das S, Wang H, Wang Y, Lui J et al. Peptide neurotransmitters activate a cation channel complex of NALCN and UNC-80. Nature 2009; 457: 741\u2013744.","journal-title":"Nature"},{"key":"136_CR42","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/35012069","volume":"405","author":"P Murtra","year":"2000","unstructured":"Murtra P, Sheasby AM, Hunt SP, De Felipe C. Rewarding effects of opiates are absent in mice lacking the receptor for substance P. Nature 2000; 405: 180\u2013183.","journal-title":"Nature"},{"key":"136_CR43","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/S0028-3908(02)00295-2","volume":"43","author":"TL Ripley","year":"2002","unstructured":"Ripley TL, Gadd CA, De Felipe C, Hunt SP, Stephens DN. Lack of self-administration and behavioural sensitisation to morphine, but not cocaine, in mice lacking NK1 receptors. Neuropharmacology 2002; 43: 1258\u20131268.","journal-title":"Neuropharmacology"},{"key":"136_CR44","doi-asserted-by":"publisher","first-page":"8271","DOI":"10.1523\/JNEUROSCI.23-23-08271.2003","volume":"23","author":"CA Gadd","year":"2003","unstructured":"Gadd CA, Murtra P, De Felipe C, Hunt SP. Neurokinin-1 receptor-expressing neurons in the amygdala modulate morphine reward and anxiety behaviors in the mouse. J Neurosci 2003; 23: 8271\u20138280.","journal-title":"J Neurosci"},{"key":"136_CR45","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.neuroscience.2005.07.025","volume":"135","author":"A Lessard","year":"2005","unstructured":"Lessard A, Pickel VM. Subcellular distribution and plasticity of neurokinin-1 receptors in the rat substantia nigra and ventral tegmental area. Neuroscience 2005; 135: 1309\u20131323.","journal-title":"Neuroscience"},{"key":"136_CR46","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1126\/science.1153813","volume":"319","author":"DT George","year":"2008","unstructured":"George DT, Gilman J, Hersh J, Thorsell A, Herion D, Geyer C et al. Neurokinin 1 receptor antagonism as a possible therapy for alcoholism. Science 2008; 319: 1536\u20131539.","journal-title":"Science"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/mp2017102","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mp2017102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/mp.2017.102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/mp2017102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:16:50Z","timestamp":1684433810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp2017102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,9]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["136"],"URL":"https:\/\/doi.org\/10.1038\/mp.2017.102","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,9]]},"assertion":[{"value":"4 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}